News & Events

DeepHealth, RadNet’s Digital Health division, delivered record quarterly revenue, strong commercial momentum and continued expansion of its integrated AI-powered health informatics portfolio, contributing to RadNet’s record second-quarter 2026 financial results. 

Study published in Radiology shows general radiologists achieve cancer detection rates comparable to breast imaging specialists with the integration of DeepHealth’s AI-powered workflow. The study evaluated more than 577,000 screening mammograms across more than 100 imaging sites in the US.

DeepHealth has received FDA 510(k) clearances for Breast Arterial Calcification Assessment and prior exam integration into ProFound Pro. BAC Assessment is a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease.¹ ProFound Pro with prior exam integration enables the comparison of breast tissue over time amongst prior and current exams, and will be brought to market as Mammo Dx.²

DeepHealth has received CE Marking for the Brain Health and Brain Age solutions within its Neuro Suite, CE Marking for its LumbarMR solution, and FDA 510(k) clearance and CE Marking for the Prostate AI solution within its Prostate Suite.